NEWSLETTER-2017

448 NEWSLETTER 2017 Important Legislation and Decisions regarding Competition • The Competition Board (“Board”) granted individual exemp- tion to the “Bonus Credit Card Program Sharing Agreement” signed by and between Türkiye Garanti Bankası A.Ş. and Şekerbank T.A.Ş. (28.12.2016, 16-45/723-326) • The Board granted negative clearance to the “Guide to Oc- cupational Health and Safety Rules in Subcontractor and Contractor Work in the Cement Sector” drafted by the Labor Health and Safety Committee of the Cement Industry Emp- loyers’ Union. (05.01.2017, 17-01/3-3) • The Board granted individual exemption to sublicense ag- reements related to the approval of the American Express branded cards executed between Türkiye Garanti Bankası A.Ş. and Türkiye Vakıflar Bankası T.A.O., Denizbank A.Ş., Türkiye İş Bankası A.Ş., Türkiye Ekonomi Bankası A.Ş. (28.02.2017, 17-09/106-48) • The Board granted individual exemption to the “Cooperation Agreement” regarding the presentation of the Seredite goods executed between GlaxoSmithKline İlaçları San. ve Tic. A.Ş. and Bilim İlaç San. ve Tic. A.Ş. (13.03.2017, 17-10/119-54) • The Board granted individual exemption for one year as of the decision date to the card data storage service of Bankala- rarası Kart Merkezi A.Ş., as it fulfills the conditions provided by Article 5 of Law No. 4054. (23.03.2017, 17-11/134-61) • The Board decided that the Tender Sale Contract executed between Sanofi Sağlık Ürünleri Ltd. Şti. and Aksel Ecza Deposu Ticaret A.Ş. benefits from group exemptions for drugs called Allegra, Amikozit, Amlodis, Arifay, Artril+ Dolven, Azro, Delix Protect, Eveptin+Gabtin, Festal, He- licol, Lasix, Mirtaron, Nasacort, Nortan, Piogtan, Prosek, Rifocin, Sarvas, Sarvastan, Sempriban, Tamprost, Tavanic, Trental, Zaltrap, Zepahex, Sefotak, Zentovir, Taxotere, and granted individual exemption to the Contract for the drugs called Amaryl, Antibit, Apidra, Arava, Bemiks, Bemiks